Startup recognized for innovative wearable biosensor technology, HealthPatchTM MD
SAN JOSE, CA – Vital Connect announced today it has been honored with a MEDy (Medical Entrepreneurship and Disruption) Award at Singularity University’s FutureMed 2013. The MEDy Awards are designed to recognize companies designing products and creating healthcare solutions that are industry-changing innovations.
Vital Connect is an industry pioneer of the HealthPatch MD wearable biosensor technology for use in medical applications. The HealthPatch MD biosensor is capable of capturing clinical-grade biometric measurements in a continuous, configurable and non-obtrusive manner using a small yet powerful patch worn on the chest.
Encapsulated within the HealthPatch MD are cutting-edge sensor and chip technologies which combined with Vital Connect’s proprietary algorithms, enable the device to provide clinical-grade measurements of eight core health metrics: single lead ECG, heart rate, heart rate variability, respiratory rate, skin temperature, body posture, steps and fall detection/severity. Additionally, the HealthPatch MD can provide intelligent health measurements. Processing thousands of data points per minute, Vital Connect’s sophisticated SensorFusion algorithms analyze multiple biometrics to generate measurements that are more meaningful and accurate than any individual biometric alone. These measurements can include stress, energy expenditure (caloric burn), sleep quality, and contextual heart rate, among other health predictors.
“The Vital Connect team is thrilled to be a recipient of the MEDy award. Singularity University’s FutureMed is a gathering of the leading influencers in healthcare innovation with an emphasis on exponentially growing technologies within medicine and healthcare, and to be chosen from among the many noteworthy innovations showcased during the event is an incredible honor,” said Dr. Nersi Nazari, CEO of Vital Connect.
“The healthcare industry is on the cusp of exciting changes as new technologies are being developed that will truly alter how medical care is provided to patients and that will solve challenges present in the current system. The MEDy award is presented to companies generating disruptive solutions that are driving innovation in the medical field, and Vital Connect is certainly deserving of this recognition,” said Dr. Daniel Kraft Executive Director of FutureMed.
For more information on the HealthPatch MD and its applications, visit: www.vitalconnect.com.
About Vital Connect, Inc.
Vital Connect is a Silicon Valley-based startup founded in 2011 with the goal to develop the newest generation of technologies that help address some of the most challenging healthcare issues in the world today. Vital Connect’s extensive expertise enables the company to create wireless, wearable biosensors that are small, powerful, and capable of capturing clinical-grade biometric measurements in a continuous, configurable and non-obtrusive manner. Through various partnerships, Vital Connect solutions will be available for use in hospitals, research facilities, doctor’s offices, care facilities and homes. For more information, visit: www.vitalconnect.com.
About Singularity University
Singularity University (SU) is a unique interdisciplinary, international and intercultural experience that challenges participants to use transformative, exponential technologies to address humanity’s greatest challenges. SU educates and inspires participants to discover and design sustainable organizations to positively impact humanity. Located on the campus of NASA Research Park in Silicon Valley, one of the world’s great epicenters of innovation, SU offers a 10-week graduate studies program and week long executive programs, as well as customized programs for corporations, entrepreneurs, NGOs and government. SU also offers Executive Programs in industry-specific areas, including the highly acclaimed FutureMed concentrating on the most recent breakthroughs in medicine, biotech and healthcare. For more information, visit: http://singularityu.org/.
For further information, please contact: